Work

Evaluating the benefits of the early use of GLP-1 receptor agonists

Year: 2024

Type: article

Source: The Lancet

DOI: 10.1016/s0140-6736(24)02255-4

Authors: Peter-James H Zushin, Joseph C Wu

Institutions: Stanford Medicine, Stanford Cardiovascular Institute, Stanford University

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: California Institute for Regenerative Medicine, American Heart Association, University of California, San Francisco, Center of Excellence in Regulatory Science and Innovation, National Heart, Lung, and Blood Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G4999666563, Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology, Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford, Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy

OpenAlex ID: W4404259718

FWCI: 2.361

Cites: 20

Cited by: 9

Related to: 10